BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7986312)

  • 1. Modified lipoproteins in diabetes.
    Deslypere JP
    J Intern Med Suppl; 1994; 736():69-74. PubMed ID: 7986312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The peroxidation of human glycosylated low-density lipoproteins is mediated by the superoxide radical: the protective effects of superoxide dismutase].
    Napoli C; Ambrosio G; Palumbo G; Chiariello P; Duilio C; Chiariello M
    Cardiologia; 1994 May; 39(5):345-52. PubMed ID: 8087816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein glyco-oxidation.
    Picard S
    Diabete Metab; 1995 Apr; 21(2):89-94. PubMed ID: 7621977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM
    Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats.
    Anandh Babu PV; Sabitha KE; Shyamaladevi CS
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diabetic dyslipoproteinemia.
    Steinmetz A
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma antioxidants and type 2 diabetes mellitus.
    Palanduz S; Ademoğlu E; Gökkuşu C; Tamer S
    Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):309-18. PubMed ID: 12889514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
    Persson J; Nilsson J; Lindholm MW
    Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y; Howard BV; Cowan LD; Welty TK; Schaefer CF; Wild RA; Yeh J; Lee ET
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
    Hogue JC; Lamarche B; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Mar; 57(3):380-6. PubMed ID: 18249211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypothetical connection between diabetes mellitus and free radical reactions in arteriosclerosis].
    Somogyi A; Pusztai P; Prechl J; Fehér J
    Orv Hetil; 1994 Aug; 135(33):1815-8. PubMed ID: 8072757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free radicals and diabetes mellitus].
    Hayakawa M; Kuzuya F
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):149-54. PubMed ID: 2200913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.